For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Tylosin is a macrolide-class broad spectrum antibiotic that's used in veterinary medicine to treat felines, canines and livestock. However, the drug is only used as an antibiotic in the treatment of infections in livestock. In cats, dogs, and other smaller animals, it is used predominantly for its anti-inflammatory properties to treat inflammatory conditions in the bowel. As such, it is commonly prescribed to pets that are suffering from diarrhea.
Scope of the Report:
Tylosin is a macrolide antibiotic commonly used in food animals. It is a macrolide antibiotic, mainly active against Gram-positive bacteria and mycoplasmas. It is also active against some Gram-negative bacteria, spriochetes, some rickettsia and chlamydia. According to the different materials, tylosin is divided into tylosin tartrate, tylosin phosphate, tylosin base. Tylosin tartrate is mainly cure or prevented mycoplasma diseases and respiratory diseases. And it is the most widely used type which takes up about 68.22% of the global in 2015.
There are companies adding new capacities and aims at the cost and quality leadership which shall improve profitability. As the same time, companies are focusing on technological innovation, equipment upgrades, and process improvements, to reduce costs and improve quality. The competition in tylosin market will become more intense.
The worldwide market for Tylosin is expected to grow at a CAGR of roughly 0.2% over the next five years, will reach 390 million US$ in 2024, from 390 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Tylosin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Elanco
- Huvepharma
- Tairui Pharmaceuticals
- Qilu Pharmaceutical (Inner Mongolia)
- Henan Hualun
- Top Pharm Chemical Group
- HISUN
- Lukang Shelile Pharmaceutical
- Apeloa Kangyu
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Tylosin Tartrate
- Tylosin Phosphate
- Tylosin Base
Market Segment by Applications, can be divided into
- Animal Feed Additives
- Animal Drugs
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tylosin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Tylosin, with price, sales, revenue and global market share of Tylosin in 2017 and 2018.
Chapter 3, the Tylosin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tylosin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Tylosin market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Tylosin sales channel, distributors, customers, research findings and conclusion, appendix and data source.